Open AccessPharmacological Treatment of Tachyarrhythmias in Acute Myocardial Infarction - a Review
Author(s) -
Alexandru Deaconu,
Silvia Deaconu,
Andra-Victoria Radu,
Maria Dorobanțu
Publication year - 2021
Publication title -
romanian journal of cardiology
Language(s) - English
Resource type - Journals
eISSN - 2734-6382
pISSN - 1220-658X
DOI - 10.47803/rjc.2021.31.2.311
Subject(s) - medicine , myocardial infarction , cardiology , atrial fibrillation , revascularization , ventricular fibrillation , intensive care medicine
Acute myocardial infarction (AMI) causes severe metabolic and electrophysiological changes that induce silent or symptomatic life-threatening arrhythmias. Ventricular arrhythmias and atrial fibrillation are common during the early phase of AMI and are also important prognostic factors. Rapid identification and treatment of these arrhythmias can be life-saving, since in-hospital mortality rises dramatically in patients who develop arrhythmias with a fast ventricular rate following an AMI. Along with myocardial revascularization, adequate pharmacological therapy of hemodynamically relevant arrhythmias is generally useful. Since there are no controlled randomized trials comparing different antiarrhythmic drugs (AADs) in AMI, optimal decision making is based on medical societies guidelines recommendations and clinical judgement.